Invitae

Invitae Inc. is a biotechnology company founded in 2010, specializing in next-generation sequencing (NGS)-based genetic testing services for clinical applications. The company aims to make genetic testing more affordable and accessible by aggregating various tests into a comprehensive assay. Invitae develops diagnostic panels that sequence over 600 genes associated with a wide range of conditions, including hereditary cancers, cardiovascular diseases, and rare genetic disorders. The company offers extensive genetic testing panels and incorporates RNA sequencing to enhance the accuracy of variant interpretation. Invitae has integrated artificial intelligence capabilities to improve cancer diagnostics and collaborates with pharmaceutical companies to provide free genetic testing for rare diseases. Additionally, Invitae has expanded its services to include health information technology, combining genomic and clinical data to empower patients and support healthcare decision-making. Its primary customers include hospitals, clinics, medical centers, and biopharmaceutical partners.